Inspirion Wealth Advisors, LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Inspirion Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 04, 2024	BUY	$69.02 - $93.84 $48,314 - $65,688	700 New	700 $49,000
Q1 2024 Apr 12, 2024	SELL	$83.81 - $99.0 $3.34 Million - $3.94 Million	-39,800 Reduced 99.5%	200 $17,000
Q4 2023 Jan 10, 2024	BUY	$76.22 - $98.51 $3.03 Million - $3.92 Million	39,800 Added 19900.0%	40,000 $3.86 Million
Q3 2023 Oct 13, 2023	BUY	$85.07 - $94.48 $17,014 - $18,896	200 New	200 $17,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Inspirion Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspirion Wealth Advisors, LLC with notifications on news.